Literature DB >> 22019188

Synthesis and biological evaluation of 2-indolinone derivatives as potential antitumor agents.

Hongbin Zou1, Liang Zhang, Jingfeng Ouyang, Marc A Giulianotti, Yongping Yu.   

Abstract

Three series of 3-substituted-indolin-2-ones and azaindolin-2-ones have been synthesized and showed potential antiproliferative activity to cancer cell lines. The inhibition activities on VEGF-induced VEGFR phosphorylation were observed for selected 2-indolinones. Among the compounds synthesized, 5-fluoroindolin-2-one derivative 23 with a pyridone unit showed the most significant enzymatic and cellular activities. Flow cytometric analysis indicates that 23 plays a role in suppressing HCT-116 cell proliferation via G1 phase arrest and apoptosis in a dose dependent manner. The binding mode of compound 23 complexed with VEGFR-2 was predicted using FlexX algorithm. Described here are the chemistry and biological testing for these series which will guide the design and optimization of novel 2-indolione antitumor agents.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22019188     DOI: 10.1016/j.ejmech.2011.10.009

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  6 in total

1.  Design and synthesis of thiazolidine-2,4-diones hybrids with 1,2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: in-vitro anticancer evaluation and in-silico studies.

Authors:  Mohammed S Taghour; Hazem Elkady; Wagdy M Eldehna; Nehal M El-Deeb; Ahmed M Kenawy; Eslam B Elkaeed; Aisha A Alsfouk; Mohamed S Alesawy; Ahmed M Metwaly; Ibrahim H Eissa
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

2.  Synthesis of a library of tricyclic azepinoisoindolinones.

Authors:  Bettina Miller; Shuli Mao; Kara M George Rosenker; Joshua G Pierce; Peter Wipf
Journal:  Beilstein J Org Chem       Date:  2012-07-13       Impact factor: 2.883

3.  The indolinone MAZ51 induces cell rounding and G2/M cell cycle arrest in glioma cells without the inhibition of VEGFR-3 phosphorylation: involvement of the RhoA and Akt/GSK3β signaling pathways.

Authors:  Joo-Hee Park; Yoo-Jin Shin; Tae-Ryong Riew; Mun-Yong Lee
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

4.  Novel 3-((2-chloroquinolin-3-yl)methylene)indolin-2-one derivatives produce anticancer efficacy in ovarian cancer in vitro.

Authors:  Chandrabose Karthikeyan; Haneen Amawi; Charles R Ashby; Vishwa M Khare; Veronica Jones; N S Hari Narayana Moorthy; Piyush Trivedi; Amit K Tiwari
Journal:  Heliyon       Date:  2019-05-14

5.  Synthesis, Spectroscopic Identification and Molecular Docking of Certain N-(2-{[2-(1H-Indol-2-ylcarbonyl) Hydrazinyl](oxo)Acetylphenyl)Acetamides and N-[2-(2-{[2-(Acetylamino)Phenyl](oxo)Acetylhydrazinyl)-2-Oxoethyl]-1H-Indole-2-Carboxamides: New Antimicrobial Agents.

Authors:  Maha S Almutairi; Azza S Zakaria; Reem I Al-Wabli; I Hubert Joe; Ali S Abdelhameed; Mohamed I Attia
Journal:  Molecules       Date:  2018-04-29       Impact factor: 4.411

6.  RNAm expression profile of cancer marker genes in HepG2 cells treated with different concentrations of a new indolin-3-one from Pseudomonas aeruginosa.

Authors:  Lucas Milanez Benicio; Ane Stefano Simionato; Cláudio Roberto Novello; Jeconias Rocha Guimarães; Ingrid Felicidade; Admilton Gonçalves de Oliveira; João Carlos Palazzo de Mello; Mário Sérgio Mantovani; Andreas Lazaros Chryssafidis; Galdino Andrade; Ilce Mara de Syllos Colus; Marcelo Tempesta de Oliveira
Journal:  Sci Rep       Date:  2018-08-24       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.